CD5-eiwit (C-His, mens)

CD5

LEU1, T1

C-His

< 1.0 EU per μg protein as determined by the LAL method.

1.Flow cytometric analysis of anti-CD5 CAR expression. 5e5 of anti-CD5 CAR-293 cells were stained with 100 μL of 5 μg/mL of AF 488-conjugated human CD5 Protein (Site-Specific AF 488 Conjugation, His Tag, Cat. No. 11027-H86H-SD) and negative control protein. Non-transduced 293 cells were used as a control (left) . AF 488 signal was used to evaluate the binding activity (QC tested) . 2.Binding activity of AF 488-conjugated CD5 protein to PBMC cells. PBMC cells were stained with PE conjugated anti-CD3 antibody and AF 488-conjugated human CD5 Protein (Site-Specific AF 488 Conjugation, His Tag, Cat. No. 11027-H86H-SD) and detected by flow cytometry. PE signal was used to evaluate the content of CD3+ T cells in PBMCs. AF 488 signal was used to evaluate the non-specific binding activity to PBMCs (QC tested) . 3.1E5 of mouse Anti-CD5 antibody conjugated beads (6-8 μm) were stained with a series of concentrations of AF 488-conjugated human CD5 Protein (Site-Specific AF 488 Conjugation, His Tag, Cat. No. 11027-H86H-SD) . Binding activity was quantified based on AF 488 fluorescence. The recommended working concentration is 4 μg/mL (end-user titration is recommended for optimal performance) .

Met1-Pro372

The protein has a predicted molecular mass of 42 kDa.

Human